UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~November~~February 3028, ~~2025~~2026

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 333-127953

SOLARWINDOW TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Nevada		59-3509694
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
9375 E. Shea Blvd., Suite 107-B
Scottsdale, AZ		85260
(Address of principal executive offices)		(Zip Code)

9375 E. Shea Blvd., Suite 107-B
Scottsdale, AZ		85260
(Address of principal executive offices)		(Zip Code)

(800) 213-0689

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act).

Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act: None

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 65,779,045 shares of common stock, par value $0.001, were outstanding on ~~January~~ 8April 9, 2026.

SOLARWINDOW TECHNOLOGIES, INC.

FORM 10-Q

For the Quarterly Period Ended ~~November~~February 3028, ~~2025~~2026

Table of Contents

PART I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements	1
Condensed Consolidated Balance Sheets	1
Consolidated Balance Sheets	1
Condensed Consolidated Statements of Operations and Comprehensive Loss	2
Consolidated Statements of Operations and Comprehensive Loss	2
Condensed Consolidated Statements of Stockholders’ Equity	3
Consolidated Statements of Stockholders’ Equity	3
Condensed Consolidated Statements of Cash Flows	4
Consolidated Statements of Cash Flows	4
Notes to Condensed Consolidated Financial Statements	5
Notes to Consolidated Financial Statements	5
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	10
Item 3. Quantitative and Qualitative Disclosures About Market Risk	14
Item 4. Controls and Procedures	14
PART II OTHER INFORMATION
Item 1A. Risk Factors	15
Item 6. Exhibits	15
Signatures	16
Certifications

PART I — FINANCIAL INFORMATION

Item 1. ~~Condensed~~ Consolidated Financial Statements

SOLARWINDOW TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	November 30,			August 31,
	February 28,			August 31,
	2025			2025
	2026			2025
ASSETS		(Unaudited)
Current assets
Cash and cash equivalents	$	5,~~898~~391,~~000~~821		$	6,555,642
Deferred research and development costs		4434,~~619~~274			30,687
Prepaid expenses and other current assets		~~113~~79,~~182~~028			15,836
Total current assets		65,~~055~~505,~~801~~123			6,602,165
Property and Equipment, net		6964,~~054~~167			43,089
Total assets	$	65,~~124~~569,~~855~~290		$	6,645,254
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses	$	~~205~~187,~~984~~688		$	114,309
Related party payables		3890,~~550~~701			79,866
Total current liabilities		~~244~~278,~~534~~389			194,175
Total liabilities		~~244~~278,~~534~~389			194,175
Commitments and contingencies
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding		—-			—-
Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 shares issued and outstanding at November 30, 2025 and August 31, 2025		65,779			65,779
Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 shares issued and outstanding at February 28, 2026 and August 31, 2025		65,779			65,779
Additional paid-in capital		87,475,862			87,475,862
Accumulated deficit		(8182,~~661~~250,~~320~~740	)		(81,090,562	)
Total stockholders' equity		5,~~880~~290,~~321~~901			6,451,079
Total liabilities and stockholders' equity	$	65,~~124~~569,~~855~~290		$	6,645,254

(The accompanying notes are an integral part of these consolidated financial statements)

SOLARWINDOW TECHNOLOGIES, INC.

~~CONDENSED~~ CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

	For the Three Months Ended November 30,
	Three Months Ended February 28,						Six Months Ended February 28,
	2025			2024
	2026			2025			2026			2025
Revenue	$	—-		$	—-		$	-		$	-
Operating expenses:
Selling, general and administrative		~~464~~453,~~338~~311			~~457~~495,~~952~~692			917,648			953,644
Research and development		~~148~~170,~~851~~635			~~137~~173,~~179~~335			319,486			310,514
Total operating expenses		~~613~~623,~~189~~946			~~595~~669,~~131~~027			1,237,134			1,264,158
Loss from operations		(~~613~~623,~~189~~946	)		(~~595~~669,~~131~~027	)		(1,237,134	)		(1,264,158	)
Other income:
Interest income		4234,~~431~~526			4438,~~039~~983			76,958			83,022
Total other income		4234,~~431~~526			4438,~~039~~983			76,958			83,022
Net loss from continuing operations		(~~570~~589,~~758~~420	)		(~~551~~630,~~092~~044	)		(1,160,176	)		(1,181,136	)
Net loss from discontinued operations		—-			(~~971~~24,043	)		-			(25,014	)
Net loss attributable to common stockholders		(~~570~~589,~~758~~420	)		(~~552~~654,~~063~~087	)		(1,160,176	)		(1,206,150	)
Other comprehensive income loss:
Other comprehensive income (loss):
Foreign currency translation gain		—			2,301
Foreign currency translation gain/(loss)		-			2,368			-			4,669
Comprehensive (loss) attributable to common stockholders’	$	(~~570~~589,~~758~~420	)	$	(~~549~~651,~~762~~719	)		(1,160,176	)	$	(1,201,481	)
Loss per Share from continuing operations basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.02	)
Loss per Share from discontinued operations basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss attributable to common stockholders per share basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.02	)
Weighted average number of common shares outstanding - basic and diluted		65,779,045			53,198,399			65,779,045			53,198,399

2(The accompanying notes are an integral part of these consolidated financial statements)

~~SOLARWINDOW TECHNOLOGIES, INC.~~2

~~CONDENSED~~SOLARWINDOW ~~CONSOLIDATED~~TECHNOLOGIES, ~~STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)~~INC.

	Common Stock						Accumulated
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2025	Shares		Amount		Additional Paid-in Capital		Other Comprehensive Income (Loss)			Accumulated Deficit			Total Stockholders' Equity
Balance, August 31, 2025		65,779,045	$	65,779	$	87,475,862	$	—		$	(81,090,562	)	$	6,451,079
Net loss		—		—		—		—			(570,758	)		(570,758	)
Balance, November 30, 2025		65,779,045	$	65,779	$	87,475,862	$	—		$	(81,661,320	)	$	5,880,321
FOR THE THREE MONTHS ENDED NOVEMBER 30, 2024
Balance, August 31, 2024		53,198,399	$	53,198	$	83,538,904	$	(76,702	)	$	(78,833,284	)	$	4,682,116
Stock based compensation due to common stock purchase options		—		—		51,563		—			—			51,563
Foreign currency translation adjustment		—		—		—		2,301			—			2,301
Net loss		—		—		—		—			(552,063	)		(552,063	)
Balance, November 30, 2024		53,198,399	$	53,198	$	83,590,467	$	(74,401	)	$	(79,385,347	)	$	4,183,917

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

(The accompanying notes are an integral part of these consolidated financial statements)


					Additional		Accumulated Other						Total
FOR THE SIX MONTHS ENDED FEBRUARY 28, 2026	Common Stock				Paid-in		Comprehensive			Retained			Stockholders'
	Shares		Amount		Capital		Income (Loss)			Deficit			Equity
Balance, August 31, 2025		65,779,045	$	65,779	$	87,475,862	$	-		$	(81,090,562	)	$	6,451,079
Net loss		-		-		-		-			(570,758	)		(570,758	)
Balance, November 30, 2025		65,779,045		65,779		87,475,862		-			(81,661,320	)		5,880,321
Net Loss		-		-		-		-			(589,420	)		(589,420	)
Balance, February 28, 2026		65,779,045	$	65,779	$	87,475,862	$	-		$	(82,250,740	)	$	5,290,901

FOR THE SIX MONTHS ENDED FEBRUARY 28, 2025
Balance, August 31, 2024		53,198,399	$	53,198	$	83,538,904	$	(76,702	)	$	(78,833,284	)	$	4,682,116
Stock based compensation due to common stock purchase options		-		-		51,563		-			-			51,563
Foreign currency translation adjustment		-		-		-		2,301			-			2,301
Net loss		-		-		-		-			(552,063	)		(552,063	)
Balance, November 30, 2024		53,198,399		53,198		83,590,467		(74,401	)		(79,385,347	)		4,183,917
Stock based compensation due to common stock purchase options		-		-		51,562		-			-			51,562
Foreign currency translation adjustment		-		-		-		2,368			-			2,368
Net loss		-		-		-		-			(654,087	)		(654,087	)
Balance, February 28, 2025		53,198,399	$	53,198	$	83,642,029	$	(72,033	)	$	(80,039,434	)	$	3,583,760

3(The accompanying notes are an integral part of these consolidated financial statements)

~~SOLARWINDOW TECHNOLOGIES, INC.~~3

~~CONDENSED CONSOLIDATED~~SOLARWINDOW ~~STATEMENTS~~TECHNOLOGIES, ~~OF CASH FLOWS (UNAUDITED)~~ INC.

	For the Three Months Ended November 30,
	2025			2024
Cash flows from operating activities
Net loss from continuing operations	$	(570,758	)	$	(552,063	)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation		3,899			1,645
Stock based compensation expense		—			51,563
Changes in operating assets and liabilities:
Deferred research and development costs		(13,932	)		3,565
Prepaid expenses and other assets		(97,346	)		(74,042	)
Accounts payable and accrued expenses		91,675			(3,860	)
Related party payable		(41,316	)		45,625
Net cash used in operating activities		(627,778	)		(527,567	)
Cash flows from investing activities
Capital expenditures		(29,864	)		—
Net cash used in investing activities		(29,864	)		—
Net decrease in cash and cash equivalents		(657,642	)		(527,567	)
Cash and cash equivalents at beginning of period		6,555,642			1,249,446
Cash and cash equivalents at end of period	$	5,898,000		$	721,879
Supplemental disclosure of cash flow information:
Interest paid in cash	$	—		$	—
Income taxes paid in cash	$	—		$	—

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(The accompanying notes are an integral part of these consolidated financial statements)


	Six Months Ended February 28,
	2026			2025
Cash flows from operating activities
Net loss from continuing operations	$	(1,160,176	)	$	(1,181,136	)
Net loss from discontinued operations		-			(25,014	)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation		8,786			3,146
Stock based compensation expense		-			103,125
Changes in operating assets and liabilities:
Deferred research and development costs		(3,587	)		(18,039	)
Prepaid expenses and other assets		(63,192	)		624,233
Accounts payable and accrued expenses		73,377			4,402
Related party payable		10,835			37,357
Net cash used in operating activities		(1,133,957	)		(451,926	)

Cash flows from investing activities
Redemption of short-term investments		-			3,000,000
Capital expenditures		(29,864	)		-
Net cash provided by investing activities		(29,864	)		3,000,000
Net increase in cash and cash equivalents		(1,163,821	)		2,548,074
Cash and cash equivalents at beginning of period		6,555,642			1,249,446
Cash and cash equivalents at end of period	$	5,391,821		$	3,797,520

4(The accompanying notes are an integral part of these consolidated financial statements)

~~SOLARWINDOW TECHNOLOGIES, INC.~~4

~~NOTES~~SOLARWINDOW TOTECHNOLOGIES, ~~CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~INC.

~~(UNAUDITED)~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~NOTE 1 – Organization~~(UNAUDITED)

NOTE 1 – Organization

SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (the “Company”). SolarWindow® technology harvests light energy from the sun and from artificial light sources using a transparent and ultra-lightweight coating of organic photovoltaic (“OPV”) solar cells applied to glass and plastics, thereby generating electricity. The Company’s ticker symbol is WNDW.Organization

~~Liquidity~~SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (the “Company”). SolarWindow® technology harvests light energy from the sun and from artificial light sources using a transparent and ultra-lightweight coating of organic photovoltaic (“OPV”) solar cells applied to glass and plastics, thereby generating electricity. The Company’s ticker symbol is WNDW.

The Company has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of November 30, 2025, the Company had $5,898,000 of cash on hand, and working capital of $5,811,267. The Company believes that it currently has sufficient cash to meet its funding requirements over the next twelve months following the issuance of this Quarterly Report on Form 10-Q. However, the Company has experienced and continues to experience negative cash flows from operations, as well as an ongoing requirement for additional capital investment. The Company expects that it will need to raise additional capital to commercialize its electricity generating coatings and application methodology. The Company expects to seek to obtain that funding through financial or strategic investors. There can be no assurance as to the availability of such financings nor is it possible to determine at this time the terms and conditions upon which such financing and capital might be available.Liquidity

~~NOTE~~The 2Company –has ~~Interim~~not ~~Statement~~generated ~~Presentation~~any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of February 28, 2026, the Company had $5,392,000 of cash on hand, and working capital of $5,226,000. The Company believes that it currently has sufficient cash to meet its funding requirements over the next twelve months following the issuance of this Quarterly Report on Form 10-Q. However, the Company has experienced and continues to experience negative cash flows from operations, as well as an ongoing requirement for additional capital investment. The Company expects that it will need to raise additional capital to commercialize its electricity generating coatings and application methodology. The Company expects to seek to obtain that funding through financial or strategic investors. There can be no assurance as to the availability of such financings nor is it possible to determine at this time the terms and conditions upon which such financing and capital might be available.

~~Basis~~NOTE of2 ~~Presentation~~– ~~and~~Interim ~~Use~~Statement ~~of Estimates~~Presentation

~~The~~Basis ~~accompanying unaudited interim consolidated financial statements~~ of ~~the~~ ~~Company~~Presentation ~~as of November 30, 2025,~~ and ~~for~~Use ~~the three months ended November 30, 2025 and 2024 have been prepared pursuant to the rules and regulations~~ of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended August 31, 2025, included in our Annual Report on Form 10-K filed with the SEC on November 13, 2025.Estimates

The accompanying unaudited interim consolidated financial statements ~~have been~~of ~~prepared~~the inCompany ~~accordance~~as ~~with~~of February ~~U.S.~~28, ~~GAAP~~2026, ~~which~~and ~~requires~~for ~~management~~the tothree ~~make estimates~~ and ~~assumptions~~six ~~that~~months ~~affect~~ended ~~the~~February ~~reported~~28, ~~amounts of~~2026 ~~assets~~ and ~~liabilities~~2025 athave been ~~the~~prepared ~~date~~pursuant ofto the ~~consolidated~~rules ~~financial statements~~ and ~~the~~regulations ~~reported amounts~~ of ~~revenues and expenses during~~ the ~~accounting~~Securities ~~period.~~and ~~Actual~~Exchange ~~results~~Commission ~~may~~(“SEC”) ~~differ~~for ~~from~~quarterly reports ~~those~~on ~~estimates.~~Form ~~The~~10-Q ~~accompanying~~and ~~unaudited~~do ~~interim~~not ~~consolidated~~include ~~financial~~all ~~statements have~~of ~~been prepared on~~ the ~~same~~information ~~basis~~and asnote ~~the~~disclosures ~~audited~~required ~~financial~~by ~~statements~~U.S. ~~and~~generally ~~include~~accepted ~~all~~accounting ~~adjustments~~ principles (~~including~~“U.S. ~~normal recurring adjustments~~GAAP”) ~~that~~ ~~are, in the opinion of management, necessary~~ for acomplete ~~fair~~financial ~~presentation~~statements. ofThese ~~the~~Consolidated ~~Company’s~~Financial ~~consolidated~~Statements ~~financial~~should ~~position~~therefore asbe ofread ~~November~~in ~~30,~~conjunction ~~2025,~~with ~~results~~the ofConsolidated ~~operations,~~Financial ~~stockholders’~~Statements ~~equity~~ and ~~cash~~Notes ~~flows~~thereto for the ~~three~~fiscal ~~months~~year ended ~~November 30~~August 31, 2025, ~~and 2024.~~included ~~The~~in ~~Company~~our ~~did~~Annual ~~not~~Report ~~record~~on anForm ~~income~~10-K ~~tax~~filed ~~provision~~with ~~during~~ the ~~periods~~SEC ~~presented~~on ~~due~~November to13, ~~net taxable losses~~2025. ~~The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.~~

~~These~~The accompanying unaudited interim consolidated financial statements ~~presented~~have ~~are~~been ~~those~~prepared ofin accordance ~~the~~with ~~Company and~~U.S. GAAP, ~~for~~which requires management to make estimates and assumptions that affect the ~~prior~~reported ~~year~~amounts ~~ended~~of ~~November~~assets ~~30,~~and ~~2024,~~liabilities ~~include~~at ~~$971~~the date of ~~loss~~the ~~from~~consolidated ~~its~~financial ~~wholly~~statements ~~owned~~and ~~subsidiaries,~~the ~~SolarWindow~~reported ~~Asia~~amounts ~~(USA)~~of ~~Corp.,~~revenues and ~~SolarWindow~~expenses ~~Asia~~during Cothe accounting period. ~~Ltd~~Actual results may differ from those estimates., ~~which~~The ~~entities~~accompanying unaudited interim consolidated financial statements have been ~~dissolved~~prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the ~~beginning~~Company’s consolidated financial position as of ~~fiscal~~February 28, 2026., ~~All~~results ~~significant~~of ~~intercompany~~operations, ~~balances~~stockholders’ equity and cash flows for the three and ~~transactions~~six ~~have~~months ~~been~~ended ~~eliminated~~February 28, 2026 and 2025. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

5These consolidated financial statements presented are those of the Company. For the three and six months ended February 28, 2025, the Company recognized $24,043 and $25,014, respectively, of loss from its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd., which entities have been dissolved as of the beginning of fiscal 2026. All significant intercompany balances and transactions have been eliminated.

Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Condensed Consolidated Financial Statements” in the Annual Report.5

~~Fiscal~~Information ~~quarter~~regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Condensed Consolidated Financial Statements” in the Annual Report.

~~The~~Fiscal ~~Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s first~~ quarter ~~in fiscal 2026 and 2025 ended on November 30, 2025 and November 30, 2024, respectively.~~

~~Net~~The ~~Income~~Company’s ~~(Loss)~~quarterly ~~Per~~periods ~~Share~~end on November 30, February 28, May 31, and August 31. The Company’s second quarter in fiscal 2026 and 2025 ended on February 28, 2026 and February 28, 2025, respectively.

~~The~~Net ~~computation~~Income ~~of basic earnings per share~~ (~~“EPS”~~Loss) is ~~based~~Per on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money).Share

The ~~shares~~computation ~~listed~~of ~~below~~basic earnings per share (“EPS”) is based on the weighted average number of shares that were ~~not~~outstanding ~~included~~during inthe period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted ~~losses~~EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share ~~because~~does not assume conversion, toexercise door socontingent issuance of securities that would behave an antidilutive ~~for~~effect on earnings per share. Therefore, when calculating EPS if the ~~periods~~Company ~~presented:~~experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money).

Schedule of computation of diluted losses per share
	For the Three Months Ended November 30,
	2025		2024
Stock options		5,241,000		5,433,000
Warrants		29,247,313		16,666,667
		34,488,313		22,099,667

The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented:

Accounting Pronouncements


	Three Months Ended February 28,				Six Months Ended February 28,
	2026		2025		2026		2025
Stock options		5,206,000		5,433,000		5,206,000		5,433,000
Warrants		29,247,313		16,666,667		29,247,313		16,666,667
		34,453,313		22,099,667		34,453,313		22,099,667

~~We evaluate all~~ Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our unaudited condensed financial statements.Pronouncements

~~Recently~~We ~~Adopted~~evaluate all Accounting ~~Pronouncements~~Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our unaudited condensed financial statements.

InRecently ~~November~~Adopted ~~2023, the FASB issued~~ Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, which means ASU 2023-07 is effective for our annual periods beginning September 1, 2024, and our interim periods beginning September 1, 2025, or our current fiscal year which begins on September 1, 2025. The Company adopted the ASU 2023-07 and determined that its adoption did not have a material impact on the Company’s financial statements and related disclosures.Pronouncements

~~Recently~~In ~~Issued~~November 2023, the FASB issued Accounting ~~Pronouncements~~Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, which means ASU 2023-07 is effective for our annual periods beginning September 1, 2024, and our interim periods beginning September 1, 2025, or our current fiscal year which began on September 1, 2025. The Company adopted the ASU 2023-07 and determined that its adoption did not have a material impact on the Company’s financial statements and related disclosures.

InRecently ~~November~~Issued ~~2024,~~Accounting the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. This new guidance is designed to improve the disclosures about the types of expenses, including employee compensation, depreciation, and amortization, and costs incurred related to inventory and manufacturing activities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 on a prospective basis with optional retrospective application. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its disclosures.Pronouncements

6In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. This new guidance is designed to improve the disclosures about the types of expenses, including employee compensation, depreciation, and amortization, and costs incurred related to inventory and manufacturing activities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 on a prospective basis with optional retrospective application. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the annual income tax disclosures for the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our annual reporting periods beginning September 1, 2026, with early adoption permitted. The Company is currently assessing the impact of this guidance on its disclosures.6

~~NOTE~~In December 32023, the –FASB ~~Property~~issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the annual income tax disclosures for the effective tax rate reconciliation and ~~Equipment~~income taxes paid. ASU 2023-09 is effective for our annual reporting periods beginning September 1, 2026, with early adoption permitted. The Company is currently assessing the impact of this guidance on its disclosures.

~~Property~~NOTE ~~and~~3 ~~equipment~~– ~~consists~~Property ofand ~~the following:~~Equipment

Schedule of property and equipment
	November 30,			August 31,
	2025			2025
Computers, office equipment and software	$	26,779		$	25,525
Equipment		190,475			161,866
Total property and equipment		217,254			187,391
Accumulated depreciation		(148,200	)		(144,302	)
Property and equipment, net	$	69,054		$	43,089

Property and equipment consists of the following:

During the three months ended November 30, 2025 and 2024, the Company recognized straight-line depreciation expense of $3,899 and $1,645, respectively.

Schedule of Property and equipment
	February 28,			August 31,
	2026			2025
Computers, office equipment and software	$	26,780		$	25,525
R&D Equipment		190,475			161,866
Total property and equipment		217,254			187,391
Accumulated depreciation		(153,088	)		(144,302	)
Property and equipment, net	$	64,167		$	43,089

~~NOTE~~During the three months ended February 28, 2026 and 2025, the Company recognized straight-line depreciation expense of $4,888 –and ~~Common~~$1,501, ~~Stock~~respectively. During the six months ended February 28, 2026 and ~~Warrants~~2025, the Company recognized straight-line depreciation expense of $8,786 and $3,146, respectively.

NOTE 4 – Common Stock and Warrants

AtCommon ~~November 30, 2025, the Company had 300,000,000 authorized shares of common stock with a par value of $0.001 per share, and 65,779,045 shares of common stock outstanding.~~Stock

~~Warrants~~At February 28, 2026, the Company had 300,000,000 authorized shares of common stock with a par value of $0.001 per share, and 65,779,045 shares of common stock outstanding.

~~Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. The Series T~~ Warrants ~~may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of November 30, 2025 and August 31, 2025:~~

Schedule of warrants outstanding and exercisable
	Shares of Common Stock Issuable from Warrants Outstanding as of
	November 30,		August 31,		Weighted Average
Description	2025		2025		Exercise Price		Date of Issuance		Expiration
Series T Warrants		16,666,667		16,666,667	$	1.70		November 26, 2018		November 26, 2029
Series U Warrants		4,516,130		4,516,130	$	0.47		June 16, 2025		June 16, 2028
Series U-OS Warrants		8,064,516		8,064,516	$	0.47		June 16, 2025		June 16, 2028
Total		29,247,313		29,247,313

Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. The Series T Warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of February 28, 2026 and August 31, 2025:

NOTE 5 - Stock Options


	Shares of Common Stock Issuable from Warrants Outstanding as of			Weighted Average
Description	February 28, 2026	August 31, 2025		Exercise Price	Date of Issuance	Expiration
Series T Warrants	16,666,667	16,666,667	$	1.70	November 26, 2018	November 26, 2029
Series U Warrants	4,516,130	4,516,130	$	0.47	June 16, 2025	June 16, 2028
Series U-OS Warrants	8,064,516	8,064,516	$	0.47	June 16, 2025	June 16, 2028
Total	29,247,313	29,247,313

~~The~~NOTE ~~Company~~5 ~~measures share~~-~~based~~ ~~compensation~~Stock cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the three months ended November 30, 2025 and 2024. A summary of the Company’s stock option activity for the three months ended November 30, 2025 and related information follows:Options

7The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the six months ended February 28, 2026 and 2025. A summary of the Company’s stock option activity for the six months ended February 28, 2026 and related information follows:

Schedule of stock option activity
	Number of Shares Subject to Option Grants		Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($)
Outstanding at November 30, 2025		5,241,000		2.37		3.27 years		237,500
Outstanding at February 28, 2026		5,206,000		2.37		3.04		37,500
Exercisable at November 30, 2025		5,241,000		2.37		3.27 years		237,500
Exercisable at February 28, 2026		5,206,000		2.37		3.04		37,500

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on November 30, 2025. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $0.52 on November 30, 2025 and 1,250,000 outstanding options have an exercise price below $0.52 per share, as of November 30, 2025, there is $237,500 of intrinsic value to the Company’s vested stock options. 7

The ~~following~~aggregate intrinsic value in the table ~~sets~~above ~~forth~~represents the ~~share-based~~total ~~compensation~~pretax ~~cost~~intrinsic ~~resulting~~value for all “in-the-money” ~~from~~options (i.e. the difference between the Company’s closing stock ~~option~~price ~~grants,~~on ~~including~~the ~~those~~last ~~previously~~trading ~~granted~~day of the period covered by this report and ~~vesting~~the ~~over~~exercise ~~time~~price, multiplied by the number of shares) that ~~were~~would ~~recorded~~have been received by the option holders had all in-the-money option holders exercised their vested options on February 28, 2026. The intrinsic value of the option changes based upon the fair market value of the Company’s ~~Statements of~~common ~~Operations~~stock. ~~for~~Since the ~~three~~closing ~~months~~stock ~~ended~~price was ~~November~~$0.36 30on February 28, ~~2025~~2026 and ~~2024:~~1,250,000 outstanding options have an exercise price below $0.36 per share, as of February 28, 2026, there is $37,500 of intrinsic value to the Company’s vested stock options.

Schedule of share-based compensation
	Three Months Ended November 30,
	2025		2024
Stock compensation expense:
Selling, general and administrative	$	—	$	51,563
Total	$	—	$	51,563

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three and six months ended February 28, 2026 and 2025:

The following table summarizes information about stock options outstanding and exercisable at November 30, 2025:

Schedule of share-based compensation
	Three Months Ended February 28,				Six Months Ended February 28,
	2026		2025		2026		2025
Stock compensation expense:
Selling, general and administrative	$	-	$	51,562	$	-	$	103,125

	Schedule of stock options outstanding and exercisable
		Stock Options Outstanding						Stock Options Exercisable
Range of		Number of Shares		Weighted Average		Weighted Average		Number of Shares Subject		Weighted Average Remaining		Weighted Average
Exercise		Subject to		Contractual		Exercise		To Options		Contractual		Exercise
Prices		Outstanding Options		Life (years)		Price ($)		Exercise		Life (Years)		Price ($)
	0.33		1,250,000		3.36		0.33		1,250,000		3.36		0.33
	2.32		153,000		3.86		2.32		153,000		3.86		2.32
	2.60		2,500,000		3.19		2.60		2,500,000		3.19		2.60
	3.42		50,000		0.88		3.42		50,000		0.88		3.42
	3.46		35,000		0.10		3.46		35,000		0.10		3.46
	3.54		1,033,000		3.19		3.54		1,033,000		3.19		3.54
	4.87		110,000		2.97		4.87		110,000		2.97		4.87
	6.21		110,000		5.91		6.21		110,000		5.91		6.21
	Total		5,241,000		3.27		2.37		5,241,000		3.27		2.37

The following table summarizes information about stock options outstanding and exercisable at February 28, 2026:

NOTE 6 - Transactions with Related Persons

Schedule of Stock Options Outstanding
	Stock Options Outstanding			Stock Options Exercisable
Range of Exercise Prices	Number of Shares Subject to Outstanding Options	Weighted Average Contractual Life (years)	Weighted Average Exercise Price ($)	Number of Shares Subject To Options Exercise	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price ($)
0.33	1,250,000	3.11	0.33	1,250,000	3.11	0.33
2.32	153,000	3.62	2.32	153,000	3.62	2.32
2.60	2,500,000	2.94	2.60	2,500,000	2.94	2.60
3.42	50,000	0.64	3.42	50,000	0.64	3.42
3.54	1,033,000	2.94	3.54	1,033,000	2.94	3.54
4.87	110,000	2.72	4.87	110,000	2.72	4.87
6.21	110,000	5.67	6.21	110,000	5.67	6.21
Total	5,206,000	3.04	2.37	5,206,000	3.04	2.37

ANOTE ~~related~~6 ~~party~~- ~~with~~Transactions respect to the Company is generally defined as any person (i) (and, if a natural person, inclusive of his or her immediate family) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with ~~the~~Related Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.Persons

8A related party with respect to the Company is generally defined as any person (i) (and, if a natural person, inclusive of his or her immediate family) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s general counsel since 2005. Currently, Mr. Sierchio, as principal of Sierchio Law, LLP, serves as the Company’s general counsel on an hourly basis at the rate of $750 per hour. Fees for legal services billed by Sierchio Law, LLP totaled $74,400 and $61,700 for the three months ended November 30, 2025 and 2024, respectively. As of November 30, 2025, the Company recognized a related party payable to Sierchio Law, LLP of $26,050, including $23,550 related to legal services and $2,500 related to the quarterly board fee for the three months ended November 30, 2025. As of August 31, 2025, the Company recognized a related party payable to Sierchio Law, LLP of $54,625, including $52,125 related to legal services and $2,500 related to the quarterly board fee for the three months ended August 31, 2025.8

~~All~~Joseph ~~related~~Sierchio, ~~party~~one ~~transactions~~of ~~are~~the ~~recorded~~Company’s directors, has maintained his role as the Company’s general counsel since 2005. Currently, Mr. Sierchio, as principal of Sierchio Law, LLP, serves as the Company’s general counsel on an hourly basis at the ~~exchange~~rate ~~amount~~of ~~established~~$750 per hour. Fees for legal services billed by Sierchio Law, LLP totaled approximately $68,425 and $75,000 for the three months ended February 28, 2026 and ~~agreed~~2025, respectively, and $142,825 and $136,700 for the six months ended February 28, 2026 and 2025, respectively. As of February 28, 2026, the Company recognized a related party payable to ~~between~~Sierchio Law, LLP of $70,925, including $68,425 related ~~parties~~to legal services and ~~are~~$2,500 inrelated to the ~~normal~~quarterly ~~course~~board fee for the three months ended February 28, 2026. As of ~~business~~August 31, 2025, the Company recognized a related party payable to Sierchio Law, LLP of $54,625, including $52,125 related to legal services and $2,500 related to the quarterly board fee for the three months ended August 31, 2025.

~~Note~~All 7.related ~~Segment~~party ~~Reporting~~transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

~~The~~NOTE ~~Company~~9 ~~manages~~– ~~its~~Subsequent business on a consolidated basis and operates in one reportable segment, which is the development and application of solar generating capability to various materials. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the Chief Executive Officer as chief operating decision maker (the “CODM”) in assessing business performance and deciding how to allocate resources on a consolidated basis.Events

~~The~~Management ~~CODM~~has ~~assesses~~reviewed ~~operating~~material ~~performance~~events ~~and~~subsequent ~~makes~~of ~~resource~~the ~~allocation~~period ~~decisions primarily~~ended ~~based~~February ~~on net loss~~28, ~~cash on-hand~~ 2026 and ~~cash~~through ~~flows~~the ~~utilizing~~date ~~the~~of ~~Company’s~~filing ~~product~~of ~~development~~financial ~~timelines~~statements ~~and~~in ~~cash~~accordance ~~balances as~~with ~~key~~FASB ~~inputs~~ASC to855 ~~resource~~“Subsequent ~~allocation~~Events”. ~~The~~In ~~measure~~managements opinion, ofno ~~segment~~material ~~assets~~subsequent isevents ~~reported~~have onoccurred as of the ~~balance~~date ~~sheets~~of asthis ~~total assets~~quarterly report.

Significant expenses within loss from operations, as well as within net loss, include cost of research and development, and general and administrative expenses, which are each separately presented on the Company’s Statements of Operations. Other segment items within net income include other income and other expense.9

~~NOTE~~Item 2. 8Management’s –Discussion ~~Subsequent~~and ~~Events~~Analysis of Financial Condition and Results of Operations

~~Management~~Forward-Looking has reviewed material events subsequent of the period ended November 30, 2025 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report.Statements

9This Report on Form 10-Q contains forward-looking statements which involve assumptions and describe our future plans, strategies, and expectations, and are generally identifiable by use of words such as “may,” “will,“ “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

~~Item~~Such 2forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

~~Forward~~Although forward-~~Looking~~looking ~~Statements~~statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our filings with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

~~This~~Except ~~Report~~where onthe ~~Form~~context ~~10-Q~~otherwise ~~contains forward-looking statements which involve assumptions and describe our future plans~~requires, ~~strategies,~~ and ~~expectations,~~for ~~and~~purposes ~~are generally identifiable by use~~ of ~~words~~this ~~such~~Form as10-Q ~~“may~~only,” ~~“will,“~~the terms “~~should~~we,” “~~expect~~us,” “~~anticipate~~our,” “~~estimate,~~Company” “~~believe~~our Company,” ~~“intend,”~~ orand “~~project,~~SolarWindow” refer orto ~~the~~SolarWindow ~~negative~~Technologies, ~~of these words or other variations on these words or comparable terminology~~Inc. ~~These~~, ~~statements are expressed in good faith and based upon~~ a ~~reasonable~~Nevada ~~basis when made, but there can be no assurance that these expectations will be achieved or accomplished~~corporation.

Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.Overview

~~Although~~We ~~forward-looking~~are ~~statements~~a indeveloper ~~this report reflect the good faith judgment~~ of ~~our~~semi-transparent ~~management, forward~~electricity-~~looking~~generating ~~statements are inherently subject to known and unknown risks~~coatings, ~~business, economic~~ and ~~other~~ ~~risks~~methods ~~and~~for ~~uncertainties~~their ~~that may cause actual results to be materially different from those discussed in these forward-looking statements.~~application ~~Readers are urged not~~ to ~~place~~various ~~undue~~materials ~~reliance on these forward-looking statements~~(collectively, ~~which~~“LiquidElectricity® ~~speak only as of the date of this report~~Coatings”). ~~We assume~~When noapplied ~~obligation~~in ~~to update any forward~~ultra-~~looking~~thin ~~statements~~layers ~~in order~~ to ~~reflect any event or circumstance that may arise after the date~~rigid ~~of this report~~glass, ~~other~~and ~~than~~flexible asglass ~~may be required by applicable law or regulation. Readers are urged to carefully review~~ and ~~consider~~plastic ~~the various~~surfaces ~~disclosures made by us in~~ our ~~filings~~LiquidElectricity® ~~with~~Coatings ~~the~~transform ~~Securities~~otherwise ~~and~~ordinary ~~Exchange~~surfaces ~~Commission~~into ~~which~~photovoltaic devices ~~attempt~~capable ~~to advise interested parties~~ of ~~the~~ ~~risks~~generating ~~and~~electricity ~~factors~~from ~~that~~natural ~~may affect our business~~sun, ~~financial~~artificial ~~condition~~light, ~~results of operation~~ and ~~cash~~low, ~~flows. If one or more of these risks or uncertainties materialize~~shaded, or ifreflected ~~the~~light ~~underlying~~conditions ~~assumptions~~while ~~prove incorrect, our actual results may vary materially from those~~maintaining ~~expected or projected~~transparency.

~~Except~~We ~~where~~have ~~the~~overcome ~~context~~major ~~otherwise~~technical ~~requires,~~challenges and ~~for~~achieved ~~purposes~~many ofimportant ~~this Form~~milestones ~~10-Q~~resulting ~~only,~~in an expansion of the ~~terms~~potential ~~“we~~applications of LiquidElectricity® Coatings which span multiple industries,” ~~“us~~including architectural,” ~~“our~~automotive,” agrivoltaic, ~~“Company”~~aerospace, ~~“our~~commercial ~~Company,”~~transportation and marine. Our LiquidElectricity® Coatings are under development with support ~~“SolarWindow”~~from ~~refer~~commercial tocontract ~~SolarWindow~~firms ~~Technologies,~~and ~~Inc~~at the U.S. Department of Energy’s National Laboratory of the Rockies (NLR), aforerly ~~Nevada~~known ~~corporation~~as National Renewable Energy Laboratory (NREL), through Cooperative Research and Development Agreements.

~~Overview~~10

We ~~are~~do anot ~~developer~~currently ofhave ~~semi-transparent~~any ~~electricity-generating coatings,~~commercial products and ~~methods~~there ~~for~~is ~~their~~no ~~application~~assurance tothat ~~various~~we ~~materials~~will ~~(collectively,~~successfully be ~~“LiquidElectricity®~~able ~~Coatings”). When~~to ~~applied~~design, indevelop, ~~ultra-thin~~manufacture, ~~layers~~or tosell ~~rigid~~any ~~glass,~~commercial ~~and~~products ~~flexible~~in ~~glass~~the ~~and~~future. ~~plastic~~Our ~~surfaces~~product ~~our~~development ~~LiquidElectricity®~~programs ~~Coatings~~involve ~~transform~~ongoing ~~otherwise~~R&D ~~ordinary~~and ~~surfaces~~product ~~into~~development ~~photovoltaic~~efforts, ~~devices~~and ~~capable~~the commitment of ~~generating~~significant ~~electricity~~resources ~~from~~to ~~natural~~support ~~sun,~~the ~~artificial~~extensive ~~light~~invention, ~~and low~~design, ~~shaded~~engineering, ortesting, ~~reflected~~prototyping, ~~light~~and ~~conditions~~intellectual ~~while~~property ~~maintaining~~initiatives ~~transparency~~carried out by our contract engineers, scientists, and consultants.

We ~~have~~plan ~~overcome~~to ~~major~~market ~~technical~~any ~~challenges~~SolarWindow® Products we commercialize through co-marketing and ~~achieved~~co-promotion, ~~many~~licensing, ~~important~~and ~~milestones~~distribution ~~resulting~~arrangements inwith anthird ~~expansion~~party ofcollaborators, to advance the ~~potential~~technical ~~applications~~development and subsequent commercialization of ~~LiquidElectricity~~our SolarWindow® ~~Coatings~~products. We are actively seeking additional technology and product licensing, joint venture arrangements, and manufacturing process integration relationships with commercial partners and industry; and organizations which ~~span~~have ~~multiple~~established technical ~~industries~~competencies, ~~including~~market ~~architectural~~reach, ~~automotive,~~and ~~agrivoltaic~~mature distribution networks in the solar PV, ~~aerospace~~building-integrated PV, ~~commercial~~and ~~transportation~~alternative and ~~marine~~renewable energy market industries. ~~Our~~We ~~LiquidElectricity® Coatings~~believe ~~are~~that ~~under~~this ~~development~~approach ~~with~~could ~~support~~provide ~~from~~immediate access to existing distribution channels which can increase market penetration and commercial ~~contract~~acceptance ~~firms~~of our products and atenable ~~the~~us ~~U.S.~~to ~~Department~~avoid ofexpending ~~Energy’s~~significant ~~National~~funds ~~Laboratory~~ for development of ~~the~~a large ~~Rockies~~sales ~~(NLR),~~and ~~forerly~~marketing ~~known~~organization. asWe ~~National~~have ~~Renewable~~not ~~Energy~~yet ~~Laboratory~~entered ~~(NREL),~~into ~~through~~any ~~Cooperative~~such ~~Research~~arrangements ~~and~~for ~~Development~~these ~~Agreements~~services.

10We cannot accurately predict the amount of funding, or the time required to successfully commercialize or fabricate SolarWindow® products. The actual cost and time required to commercialize our SolarWindow® technology may vary significantly depending on, among other things, the results of our product development efforts; the cost of developing, acquiring, or licensing various enabling equipment and technologies; changes in the focus and direction of our business or product development plans; competitive and technological advances; the cost of patent filing, prosecuting, defending and enforcing claims; demonstrating compliance with regulations and standards; and manufacturing, marketing and other costs that may be associated with product fabrication. Because of this uncertainty, even if financing is available to us, we may secure insufficient funding to effectuate our business and/or product development plans.

WeAs doof ~~not~~February ~~currently~~28, ~~have~~2026, ~~any commercial products and there is no assurance that~~ we ~~will~~had ~~successfully~~working becapital ~~able~~of ~~to design~~$5, ~~develop~~226,000 ~~manufacture,~~and orcash ~~sell~~of ~~any~~$5,392,000. ~~commercial~~Based ~~products~~upon ~~in the future.~~current ~~Our~~and ~~product~~near-term ~~development~~anticipated ~~programs~~level ~~involve~~of ~~ongoing~~operations ~~R&D~~ and ~~product~~expenditures, ~~development~~we ~~efforts,~~believe ~~and~~that ~~the~~cash ~~commitment~~on ofhand ~~significant~~should ~~resources to~~be ~~support~~sufficient ~~the~~to ~~extensive~~enable ~~invention,~~us ~~design,~~to ~~engineering,~~continue operations ~~testing,~~over ~~prototyping,~~the ~~and~~next ~~intellectual~~twelve ~~property~~months ~~initiatives~~following ~~carried~~the ~~out~~issuance byof ~~our contract~~this ~~engineers,~~Quarterly ~~scientists,~~Report ~~and~~on ~~consultants~~Form 10-Q.

WeManagement ~~plan~~recognizes tothat ~~market~~in ~~any~~order ~~SolarWindow®~~for ~~Products~~us ~~we commercialize~~to ~~through~~meet ~~co-marketing~~our ~~and~~capital ~~co-promotion~~requirements, ~~licensing,~~ and ~~distribution~~continue ~~arrangements with third party collaborators,~~ to ~~advance~~operate, ~~the~~additional ~~technical~~financing ~~development~~will ~~and~~be ~~subsequent~~necessary. ~~commercialization~~We ofexpect ~~our~~to ~~SolarWindow®~~raise ~~products.~~additional Wefunds ~~are~~through ~~actively~~private ~~seeking~~or ~~additional~~public ~~technology and~~equity ~~product~~investment ~~licensing,~~in ~~joint~~order ~~venture~~to ~~arrangements,~~expand the range and ~~manufacturing~~scope ~~process~~of ~~integration~~our ~~relationships~~business ~~with~~operations. ~~commercial~~We ~~partners~~will ~~and~~seek ~~industry; and~~access ~~organizations~~to ~~which~~private ~~have~~or ~~established~~public ~~technical~~equity ~~competencies,~~markets ~~market~~but ~~reach,~~there ~~and~~is ~~mature~~no ~~distribution~~assurance ~~networks~~that such inadditional ~~the~~funds ~~solar~~will ~~PV,~~be ~~building-integrated PV,~~available ~~and~~for ~~alternative~~us ~~and~~to ~~renewable~~finance ~~energy~~our ~~market~~operations ~~industries.~~on Weacceptable ~~believe~~terms, ~~that~~if ~~this~~at ~~approach~~all. ~~could~~If ~~provide~~we ~~immediate~~are ~~access~~unable to ~~existing~~raise ~~distribution~~additional ~~channels~~capital ~~which~~or ~~can~~generate ~~increase~~positive ~~market~~cash ~~penetration~~flow, ~~and~~it ~~commercial~~is ~~acceptance~~unlikely ofthat ~~our~~we ~~products~~will ~~and~~be ~~enable~~able us to ~~avoid~~continue ~~expending~~as ~~significant funds for development of~~ a ~~large~~going ~~sales~~concern. ~~and~~The ~~marketing~~financial ~~organization.~~statements do Wenot ~~have~~include ~~not~~any ~~yet~~adjustments ~~entered~~that ~~into~~might ~~any~~result ~~such~~from ~~arrangements~~the ~~for~~outcome ~~these~~of ~~services~~this uncertainty.

WeResearch ~~cannot accurately predict the amount of funding, or the time required to successfully commercialize or fabricate SolarWindow® products. The actual cost~~ and ~~time~~Related required to commercialize our SolarWindow® technology may vary significantly depending on, among other things, the results of our product development efforts; the cost of developing, acquiring, or licensing various enabling equipment and technologies; changes in the focus and direction of our business or product development plans; competitive and technological advances; the cost of patent filing, prosecuting, defending and enforcing claims; demonstrating compliance with regulations and standards; and manufacturing, marketing and other costs that may be associated with product fabrication. Because of this uncertainty, even if financing is available to us, we may secure insufficient funding to effectuate our business and/or product development plans.Agreements

AsWe ofare ~~November~~a ~~30,~~party ~~2025,~~to wecertain ~~had~~agreements ~~working~~related ~~capital of $5,811,267 and cash of $5,898,000. Based upon current and near term anticipated level of operations and expenditures, we believe that cash on hand should be sufficient~~ to ~~enable us to continue operations over~~ the ~~next~~development ~~twelve months following the issuance~~ of ~~this~~our ~~Annual Report on Form 10-K~~technology.

~~Management~~Stevenson-Wydler ~~recognizes~~Cooperative ~~that~~Research ~~in order for us to meet our capital requirements,~~ and ~~continue~~Development toAgreement ~~operate,~~with ~~additional financing will be necessary. We expect to raise additional funds through private or public equity investment in order to expand~~ the ~~range~~Alliance ~~and scope of our business operations. We will seek access to private or public equity markets but there is no assurance that such additional funds will be available~~ for ~~us to finance our operations on acceptable~~Sustainable terms, if at all. If we are unable to raise additional capital or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Energy

On March 18, 2011, the Company and the Alliance for Sustainable Energy (“ASE”), the operator of the National Laboratory of the Rockies (“NLR”), formerly known as National Renewable Energy Laboratories (“NREL”) under its U.S. Department of Energy contract, entered into a Cooperative Research and ~~Related~~Development ~~Agreements~~Agreement (“CRADA”) to advance the commercial development of our technology, and on March 6, 2013, the Company and ASE entered into Phase II of the CRADA (collectively, the “NREL CRADA”). Under terms of the NREL CRADA, NREL researchers make use of our exclusive intellectual property (“IP”), newly developed IP, and NREL’s background IP in order to work towards specific product development goals established by the Company. Under the terms of the NREL CRADA, we agreed to reimburse Alliance for Sustainable Energy for filing fees associated with all documented, out-of-pocket costs directly related to patent application preparation and filings, and maintenance of the patent applications. Beginning in 2013, under the NREL CRADA, researchers have and will continue to work to:

We• ~~are~~improve aour ~~party~~technology toefficiency ~~certain~~and ~~agreements related to the development of our technology.~~transparency;

~~Stevenson-Wydler~~• ~~Cooperative~~optimize ~~Research~~electrical ~~and~~power ~~Development~~(current ~~Agreement~~and ~~with~~voltage) ~~the Alliance for Sustainable Energy~~output;

On• ~~March~~optimize ~~18, 2011,~~ the ~~Company~~application ~~and the Alliance for Sustainable Energy (“ASE”), the operator~~ of the ~~National~~active ~~Laboratory~~layer ofcoatings ~~the Rockies (“NLR”), formerly known as National Renewable Energy Laboratories (“NREL”) under its U.S. Department of Energy contract, entered into a Cooperative Research~~ and ~~Development~~application ~~Agreement~~processes ~~(“CRADA”)~~which to advance the commercial development of our technology, and on March 6, 2013, the Company and ASE entered into Phase II of the CRADA (collectively, the “NLR CRADA”). Under terms of the NLR CRADA, NLR researchers make ~~use~~it ofpossible our exclusive intellectual property (“IP”), newly developed IP, and NLR’s background IP in order to work towards specific product development goals established by the Company. Under the terms of the NLR CRADA, we agreed to reimburse Alliance for ~~Sustainable~~LiquidElectricity® ~~Energy~~Coatings ~~for filing fees associated with all documented, out-of-pocket costs directly related~~ to ~~patent application~~generate ~~preparation~~electricity ~~and~~on ~~filings,~~glass ~~and maintenance of the patent applications. Beginning in 2013, under the NLR CRADA, researchers have and will continue to work to:~~ surfaces;

11• develop improved electricity-generating coatings by enhancing performance, processing, reliability, and durability;

·• ~~improve~~optimize ~~our~~LiquidElectricity® ~~technology~~Coating ~~efficiency~~performance ~~and~~on ~~transparency~~flexible substrates; and

·• ~~optimize~~develop ~~electrical~~high ~~power~~speed and large area roll-to-roll (~~current~~R2R) and ~~voltage)~~sheet-to-sheet ~~output;~~coating application methods required for commercial-scale building integrated photovoltaic products and windows.

~~· optimize the application of the active layer coatings and application processes which make it possible for LiquidElectricity® Coatings to generate electricity on glass surfaces;~~11

·Over ~~develop~~the ~~improved~~course ~~electricity-generating~~of ~~coatings~~our bycollaborative ~~enhancing~~research and development efforts under the NREL CRADA, both parties have agreed to modifications to extend the period of performance. The current modification extends the period of performance to December 31, ~~processing~~2028. As of February 28, ~~reliability~~2026, the Company had a capitalized asset balance of $34,274 related to deferred research and ~~durability;~~development costs for advances to Alliance for Sustainable Energy for work to be performed under the NREL CRADA.

·Results ~~optimize~~of ~~LiquidElectricity® Coating performance on both rigid and flexible substrates; and~~Operations

·Three ~~develop~~and ~~high~~six ~~speed~~months ~~and~~ended ~~large~~February ~~area~~28, ~~roll-to-roll~~2026, ~~(R2R)~~compared ~~and sheet-~~to~~-sheet~~ ~~coating~~the ~~application~~three ~~methods~~and ~~required~~six ~~for~~months ~~commercial-scale~~ended ~~building~~February 28, ~~integrated photovoltaic products and windows.~~2025

~~Over~~A ~~the~~summary ~~course~~ of our ~~collaborative~~operating ~~research~~expenses ~~and~~for ~~development efforts under~~ the ~~NLR~~three ~~CRADA,~~and ~~both~~six ~~parties~~months ~~have~~ended ~~agreed~~February ~~to modifications to extend the period of performance. The current modification extends the period of performance to December 31~~28, ~~2028. As of November 30~~2026, ~~2025, the Company had a capitalized asset balance of $44,619 related to deferred research~~ and ~~development costs for advances to Alliance for Sustainable Energy for work to be performed under the NLR CRADA.~~2025 follows:

Results of Operations

						2026 compared to 2025
		Three Months Ended February 28,				Increase /		Percentage
		2026		2025		(Decrease)		Change
Operating expenses:
Selling, general & administrative	$	453,311	$	444,130	$	9,181		-2	%
Research and development		170,635		173,335		(2,700	)	-2	%
Stock compensation		-		51,562		(51,562	)	-100	%
Total Operating expenses	$	623,946	$	669,027	$	(45,081	)	-7	%

Three Months ended November 30, 2025, compared to the three months ended November 30, 2024

						2026 compared to 2025
		Six Months Ended February 28,				Increase /		Percentage
		2026		2025		(Decrease)		Change
Operating expenses:
Selling, general & administrative	$	917,648	$	850,519	$	67,129		8	%
Research and development		319,486		310,514		8,972		3	%
Stock compensation		-		103,125		(103,125	)	-100	%
Total Operating expense	$	1,237,134	$	1,264,158	$	(27,024	)	-2	%

~~A summary of our operating expenses for the three months ended November 30~~Selling, ~~2025,~~General and ~~2024 follows:~~Administrative

					Fiscal 2026 compared to Fiscal 2025
	Three Months Ended November 30,				Change			Percentage
	2025		2024		($)			Change
Operating expenses:
Selling, general & administrative	$	464,338	$	406,389	$	57,949			14	%
Research and development		148,851		137,179		11,672			9	%
Stock compensation		—		51,563		(51,563	)		(100	)%
Total Operating expense	$	613,189	$	595,131	$	18,058			3	%

Selling, general and administrative (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel, public company costs, insurance, and other office related costs. During the three months ended February 28, 2026 compared to the three months ended February 28, 2025, SG&A remained flat. During the six months ended February 28, 2026, compared to the six months ended February 28, 2025, SG&A costs increased by $67,129 primarily due to higher personnel costs ($21,000), travel costs ($16,000), professional fees ($9,000), and other SG&A costs ($16,000).

~~Selling, General and Administrative~~12

~~Selling,~~Research ~~general~~ and ~~administrative~~Product (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel, public company costs, insurance, and other office related costs. During the three months ended November 30, 2025 compared to the three months ended November 30, 2024, SG&A costs increased $57,949 primarily due to increased travel and professional fees.Development

Research and ~~Product~~ Development (“R&D”) costs represent costs incurred to develop our SolarWindow® technology and are incurred pursuant to our research agreements and agreements with other third-party providers and certain internal R&D cost allocations. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead, contract services and other costs. R&D costs are expensed when incurred, except for non-refundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. During the three months ended February 28, 2026, compared to the three months ended February 28, 2025, R&D costs remained flat. During the six months ended February 28, 2026 compared to the six months ended February 28, 2025, R&D costs increased primarily as a result of an increase in NREL and consultant costs ($21,000) and asset depreciation ($4,000) offset by lower R&D supplies costs ($16,000).

~~Research~~Stock ~~and~~Based Development (“R&D”) costs represent costs incurred to develop our SolarWindow® technology and are incurred pursuant to our research agreements and agreements with other third-party providers and certain internal R&D cost allocations. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead, contract services and other costs. R&D costs are expensed when incurred, except for non-refundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. During the three months ended November 30, 2025, compared to the three months ended November 30, 2024, R&D costs increased primarily as a result of an increase in personnel and CRADA costs.Compensation

12The Company grants stock options to its directors, employees and consultants. Stock compensation represents the expense associated with the amortization of our stock options. Expense associated with equity-based transactions is calculated and expensed in our financial statements as required pursuant to various accounting rules and is non-cash in nature. Stock based compensation expense decreased to zero during the three and six months ended February 28, 2026 compared to the three months ended February 28, 2025 due to full vesting of all outstanding grants.

~~Stock~~Net ~~Based~~loss ~~Compensation~~from continuing operations

~~The~~Consolidated ~~Company~~net ~~grants~~loss ~~stock~~from ~~options~~continuing tooperations ~~its~~decreased ~~directors~~$40,624 to $589,420 for the three months ended ~~employees~~February ~~and~~28, ~~consultants.~~2026, ~~Stock~~as ~~compensation~~compared ~~represents~~to ~~the~~a ~~expense~~net ~~associated~~loss ~~with~~from ~~the~~continuing ~~amortization~~operations of ~~our~~$630,044 ~~stock~~for ~~options.~~the ~~Expense~~three ~~associated with~~months ~~equity-based~~ended ~~transactions~~February is28, ~~calculated~~2025. ~~and~~Consolidated net ~~expensed~~loss infrom ~~our~~continuing ~~financial~~operations ~~statements~~decreased as$20,960 ~~required~~to ~~pursuant~~$1,160,176 tofor ~~various~~the ~~accounting~~six ~~rules and~~months isended ~~non-cash~~February in28, ~~nature.~~2026, ~~Stock~~as ~~based~~compared ~~compensation~~to ~~expense~~a ~~decreased~~net loss tofrom ~~zero~~continuing ~~during~~operations of $1,181,136 for the ~~three~~six months ended ~~November~~February 3028, 2025. ~~compared to~~The decrease for the three-and ~~months~~six-month ~~ended~~periods is ~~November~~primarily ~~30,~~due ~~2024~~to ~~due~~lower stock based compensation offset by higher costs related to ~~full~~R&D, ~~vesting~~personnel, oftravel ~~all~~and ~~outstanding~~other ~~grants~~SG&A costs.

~~Net~~Liquidity ~~loss~~and ~~from~~Capital ~~continuing operations~~Resources

~~Consolidated~~Our ~~net~~primary ~~loss~~cash ~~from~~needs ~~continuing~~are ~~operations~~for ~~increased $19~~personnel,~~666~~ ~~to $570~~professional,~~758~~ R&D ~~for~~related ~~the~~fees ~~three~~and ~~months~~other administrative ~~ended~~costs. ~~November~~Our ~~30,~~principal ~~2024,~~source asof ~~compared~~liquidity tois acash. ~~net~~As ~~loss~~ of ~~$551~~February 28,~~092~~ ~~for~~2026 and August 31, 2025, the ~~three~~Company ~~months~~had ~~ended~~cash ~~November~~of 30$5,392,000 ~~2024~~and ~~due~~$6,556,000, torespectively. ~~higher~~We ~~SG&A~~have ~~and~~financed ~~R&D~~our ~~costs~~operations ~~offset~~primarily byfrom ~~lower~~the ~~stock~~sale ~~compensation~~of ~~expense~~equity and debt securities.

~~Liquidity~~The ~~and~~following ~~Capital~~table ~~Resources~~presents a summary of our cash flows for the periods indicated:

Our primary cash needs are for personnel, professional and R&D related fees and other administrative costs. Our principal sources of liquidity are cash and short-term investments. As of November 30, 2025, and August 31, 2025, the Company had cash of $5,898,000 and $6,555,642, respectively. We have financed our operations primarily from the sale of equity and debt securities.

		Six Months Ended February 28,						2026 compared
		2026			2025			to 2025
Net cash used in operating activities	$	(1,133,957	)	$	(451,926	)	$	(682,031	)
Net cash provided by (used in) investing activities		(29,864	)		3,000,000			(3,029,864	)
Net increase (decrease) in cash and cash equivalents	$	(1,163,821	)	$	2,548,074		$	(3,711,895	)

~~The~~Operating ~~following~~Activities ~~table~~- ~~presents~~Operating aactivities ~~summary~~consist of ~~our~~net loss adjusted for certain non-cash items, including depreciation, stock-based compensation expense, and the effect of changes in working capital. The amount of ~~flows~~cash ~~for~~used during the ~~periods~~six ~~indicated:~~months ended February 28, 2026 compared to cash used during the six months ended February 28, 2025 increased $682,031 due primarily to the absence in the current year of the receipt of $608,000 related to the refund of an equipment deposit and $74,000 primarily related to higher operating costs for personnel, R&D, travel, and changes in working capital.

	Three Months Ended November 30,
	2025			2024			Change
Net cash used in operating activities	$	(627,778	)	$	(527,567	)	$	(100,211	)
Net cash used in investing activities		(29,864	)		—			(29,864	)
Net decrease in cash and cash equivalents	$	(657,642	)	$	(527,567	)	$	(130,075	)

Operating Activities - Operating activities consist of net loss adjusted for certain non-cash items, including depreciation, stock-based compensation expense, and the effect of changes in working capital. Cash used in operating activities increased $100,211 during the three months ended November 30, 2025 compared to the three months ended November 30, 2024 due to higher cash outlays for personnel, R&D, travel, professional fees and changes in working capital.Indebtedness

~~Investing Activities – Investing used cash of $29,864 during the three months ended November 30, 2025 due to the purchase of coating equipment~~None.

~~Indebtedness~~Other Contractual Obligations

None.

~~Other~~Off-Balance ~~Contractual~~Sheet ~~Obligations~~Arrangements

~~None~~There were no off-balance sheet arrangements for the three and six months ended February 28, 2026 and 2025.

~~Off-Balance~~Recently ~~Sheet~~Issued ~~Arrangements~~Accounting Standards

~~There~~For ~~were~~more noinformation ~~off-balance~~regarding ~~sheet~~recent ~~arrangements~~accounting ~~for the~~standards ~~three~~and ~~months~~their ~~ended~~impact ~~November~~to ~~30,~~our ~~2025~~results of operations and ~~2024~~financial position, see “Note 2- Summary of Significant Accounting Policies” to our Financial Statements.

13Critical Accounting Policies

~~Recently~~Management’s ~~Issued~~discussion ~~Accounting~~and ~~Standards~~analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in our Quarterly Report on Form 10-Q for the three months ended February 28, 2026.

~~For~~Related ~~more~~Party information regarding recent accounting standards and their impact to our results of operations and financial position, see “Note 2- Summary of Significant Accounting Policies” to our Financial Statements.Transactions

~~Critical~~For ~~Accounting~~a ~~Policies~~discussion of our Related Party Transactions, see “Note–6 - Transactions With Related Persons” to our Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.

~~Management’s~~Corporate discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in our Quarterly Report on Form 10-Q for the three months ended November 30, 2024.Information

~~Related~~SolarWindow ~~Party~~Technologies, ~~Transactions~~Inc., a Nevada corporation, was incorporated in 1998. The Company’s executive offices are located at 9375 E Shea Blvd., Suite 107-B, Scottsdale AZ 85260. The Company’s telephone number is (800) 213-0689. Our Internet address is www.solarwindow.com. We make available free of charge through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC”). The information accessible through our website is not a part of this Quarterly Report on Form 10-Q.

~~For a discussion of our Related Party Transactions, see “Note–6 - Transactions With Related Persons”~~Item to3. ~~our~~Quantitative ~~Financial~~and ~~Statements~~Qualitative ~~included~~Disclosures ~~elsewhere~~About inMarket ~~this Quarterly Report on Form 10-Q.~~Risk

~~Corporate~~Market ~~Information~~risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates. We do not hold or issue financial instruments for trading purposes.

~~SolarWindow~~Item ~~Technologies, Inc~~4., aControls Nevada corporation, was incorporated in 1998. The Company’s executive offices are located at 9375 E Shea Blvd., Suite 107-B, Scottsdale AZ 85260. The Company’s telephone number is (800) 213-0689. Our Internet address is www.solarwindow.com. We make available free of charge through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and ~~amendments~~ to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC”). The information accessible through our website is not a part of this Quarterly Report on Form 10-Q.Procedures

~~Item~~Disclosure 3.Controls ~~Quantitative~~ and ~~Qualitative Disclosures About Market Risk~~Procedures

~~Market~~Our ~~risk~~Acting ~~represents~~Principal ~~the~~Executive ~~risk~~Officer ofand ~~loss~~Principal ~~that~~Financial ~~may~~Officer ~~impact~~(“Management”), after evaluating the effectiveness of our ~~financial~~disclosure ~~position~~controls ~~due~~and toprocedures ~~adverse~~(as ~~changes~~defined in ~~financial~~Rule ~~market~~13a-15(e) ~~prices~~under the Securities Exchange Act of 1934, as amended) as of February 28, 2026, have concluded that, as of such date, our disclosure controls and ~~rates~~procedures were effective at the reasonable assurance level. ~~Our~~Disclosure ~~market~~controls ~~risk~~and ~~exposure~~procedures isinclude, ~~primarily~~without ~~the~~limitation, ~~result~~controls ofand procedures designed to ~~fluctuations~~ensure that information required to be disclosed by an issuer in ~~interest~~the ~~rates~~reports that it files or submits under the Exchange Act is accumulated and ~~foreign~~communicated ~~currency~~to ~~exchange~~the ~~rates.~~issuer’s Wemanagement, doincluding ~~not~~its ~~hold~~principal orexecutive ~~issue~~and principal financial ~~instruments~~officers, ~~for~~or ~~trading~~persons ~~purposes~~performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

~~Item 4. Controls and Procedures~~14

~~Disclosure~~Management ~~Controls~~does not expect that the Company’s disclosure controls or the Company’s internal controls will prevent all errors and ~~Procedures~~all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We will conduct periodic evaluations of our internal controls to enhance, where necessary, our procedures and controls.

~~Our~~Changes ~~Principal~~in ~~Executive~~Internal ~~Officer~~Control ~~and~~Over ~~Principal~~ Financial ~~Officer~~ (“Management”), after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of November 30, 2025, have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.Reporting

~~Management~~There ~~does~~were ~~not~~no ~~expect~~changes ~~that~~in ~~the~~our ~~Company’s disclosure controls or the Company’s~~ internal ~~controls will prevent all errors and all fraud. A~~ control ~~system,~~over nofinancial ~~matter~~reporting ~~how~~identified ~~well~~in connection ~~conceived~~with ~~and operated, can provide only reasonable, not absolute, assurance that~~ the ~~objectives~~evaluation ofdescribed ~~the~~above ~~control system are met. Further, the design of a control system must reflect the fact~~ that ~~there~~occurred ~~are~~during ~~resource constraints, and~~ the ~~benefits~~three ofmonths ~~controls~~ended ~~must~~February ~~be considered relative to their costs. Because of the inherent limitations in all control systems~~28, no2026 ~~evaluation of controls can provide absolute assurance~~ that ~~all control issues and instances of fraud, if any,~~ have ~~been~~materially ~~detected.~~affected ~~Because~~or ~~of the inherent limitations in a cost-effective control~~are ~~system,~~reasonably ~~misstatements~~likely ~~due~~ to ~~error~~materially oraffect ~~fraud may occur and not be detected. We will conduct periodic evaluations of~~ our internal ~~controls to~~control ~~enhance,~~over ~~where~~financial ~~necessary, our procedures and controls~~reporting.

14PART II – OTHER INFORMATION

~~Changes~~Item in1A. ~~Internal~~Risk ~~Control Over Financial Reporting~~Factors

~~There~~In ~~were~~addition noto ~~changes~~the other information set forth in ~~our~~this ~~internal~~report, ~~control~~you ~~over financial~~should ~~reporting~~carefully ~~identified~~consider the factors discussed in ~~connection~~Part I, ~~with~~“Item 1A. Risk ~~the~~Factors” ~~evaluation~~in ~~described~~our ~~above~~Annual ~~that~~Report ~~occurred~~on ~~during~~Form 10-K ~~the~~filed ~~three~~with ~~months~~the ~~ended~~SEC on November 30 13, 2025, ~~that~~for ~~have~~the year ended August 31, 2025, which could materially ~~affected~~affect our business, financial condition, financial results, or ~~are~~future ~~reasonably~~performance. ~~likely~~There tohave ~~materially~~been ~~affect~~no material changes from the risk factors previously disclosed in our ~~internal~~Annual ~~control~~Report ~~over~~on ~~financial~~Form 10-K ~~reporting~~for the year ended August 31, 2025.

~~PART~~Item II6. ~~– OTHER INFORMATION~~Exhibits

Item 1A. Risk Factors

Exhibit No.	Description of Exhibit
31.1	Certification of the Principal Executive Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

31.2	Certification of the Principal Financial Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

32.1	Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101.INS	Inline XBRL Instance Document**
101.SCH	Inline XBRL Taxonomy Extension Schema Document**
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document**
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document**
104	Cover Page Interactive Data File (embedded within the Inline XBRL Document)

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K filed with the SEC on November 13, 2025, for the year ended August 31, 2025, which could materially affect our business, financial condition, financial results, or future performance. There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended August 31, 2025.____________________

~~Item~~*Filed ~~6. Exhibits~~herewith

~~Exhibit~~** NoFurnished herewith. ~~Description~~XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of ~~Exhibit~~a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

31.1 Certification of the Principal Executive Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*15

31.2 Certification of the Principal Financial Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*SIGNATURE

~~32.1~~Pursuant ~~Certification~~to of the ~~Principal~~requirements ~~Executive~~of ~~Officer~~the ~~and~~Securities ~~Principal~~Exchange ~~Financial~~Act ~~Officer~~of ~~Pursuant~~1934, tothe 18registrant ~~U.S.C.~~has ~~Section~~duly ~~1350,~~caused Asthis report ~~Adopted~~to ~~Pursuant~~be tosigned ~~Section~~on ~~906~~its ofbehalf by the ~~Sarbanes-Oxley~~undersigned ~~Act~~thereunto ofduly 2002*authorized.

	101.INS	Inline XBRL Instance Document**
	101.SCH	Inline XBRL Taxonomy Extension Schema Document**
	101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document**
	101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document**
	101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document**
	101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document**

SolarWindow Technologies, Inc.

*FiledBy: ~~herewith~~/S/Amit Singh Amit Singh Chief Executive Officer (Principal Executive Officer) Date: April 9, 2026 By: /S/ Justin Frere Justin Frere, CPA Interim Chief Financial Officer (Principal Financial Officer) Date: April 9, 2026

** Furnished herewith. XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.16

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SolarWindow Technologies, Inc.

By: /S/ Amit Singh Amit Singh Chief Executive Officer (Principal Executive Officer) Date: January 9, 2026 By: /S/ Justin Frere Justin Frere, CPA Interim Chief Financial Officer (Principal Financial Officer) By: January 9, 2026

Filing Compare · SolarWindow Technologies, Inc.